ProMIS Neurosciences Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell PMN and other ETFs, options, and stocks.About PMN
ProMIS Neurosciences, Inc. engages in the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases. It focuses on the progression of Alzheimer's disease, amyotrophic lateral sclerosis, and Parkinson's disease.
CEONeil K. Warma
CEONeil K. Warma
Employees11
Employees11
HeadquartersToronto, Ontario
HeadquartersToronto, Ontario
Founded2004
Founded2004
Employees11
Employees11
PMN Key Statistics
Market cap132.28M
Market cap132.28M
Price-Earnings ratio-0.76
Price-Earnings ratio-0.76
Dividend yield—
Dividend yield—
Average volume229.41K
Average volume229.41K
High today$14.60
High today$14.60
Low today$13.96
Low today$13.96
Open price$14.60
Open price$14.60
Volume23.38K
Volume23.38K
52 Week high$27.40
52 Week high$27.40
52 Week low$6.27
52 Week low$6.27
Stock Snapshot
The current ProMIS Neurosciences Inc.(PMN) stock price is $14.17, with a market capitalization of 132.28M. The stock trades at a price-to-earnings (P/E) ratio of -0.76.
As of 2026-08-11, ProMIS Neurosciences Inc.(PMN) stock has fluctuated between $13.96 and $14.60. The current price stands at $14.17, placing the stock +1.5% above today's low and -2.9% off the high.
ProMIS Neurosciences Inc.(PMN) shares are trading with a volume of 23.38K, against a daily average of 229.41K.
In the last year, ProMIS Neurosciences Inc.(PMN) shares hit a 52-week high of $27.40 and a 52-week low of $6.27.
In the last year, ProMIS Neurosciences Inc.(PMN) shares hit a 52-week high of $27.40 and a 52-week low of $6.27.
Analyst ratings
100%
of 8 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own PMN. This list is generated using Robinhood data, and it’s not a recommendation.